On the other hand, we found a positive correlation between VDR expression on CD3+ lymphocytes and CD14+ monocytes in patients with psoriasis before the treatment’s start, which ceased to be significant after 24 weeks of the Etanercept treatment. The gene discussed is CD14; the disease is psoriasis.